跳至主要内容
临床试验/JPRN-UMIN000004074
JPRN-UMIN000004074尚未招募未知

A study on recombinant thrombomodulin alfa in patients with disseminated intravascular coagulation (DIC) caused by sepsis receiving continuous hemodiafiltration (CHDF). - A study on recombinant thrombomodulin for septic DIC patients receiving CHDF.

Chiba University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Chronic kidney disease 2. Patients showing intracranial, pulmonary or gastrointestinal hemorrhage. 3. Patients with a history of hypersensitivity to rTM. 4. Pregnant women, nursing mothers or possibly pregnant women. 5. Other patients judged to be inappropriate at the discretion of investigators.

研究者

发起方
Chiba University Graduate School of Medicine

相似试验